Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    UBS Picks Only One Favourite In Pharma Sector; Cuts Target Price For Cipla, Lupin And More

    3 days ago

    UBS has cut target prices for major Indian pharma stocks. Sun Pharma remains the only buy recommendation thanks to its recent semaglutide launch.
    Click here to Read More
    Previous Article
    IPO GMP Buzz: Powerica Vs Amir Chand Jagdish Kumar Vs Sai Parenteral Grey Market Trends Signal Mixed Market Sentiment
    Next Article
    Who Is Aryaman Birla, New RCB Chairman And Former Rajasthan Royals Player?

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment